AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts

Akira Kondo(Gilead Sciences (United States)), Haruhiko Tokuda(National Center for Geriatrics and Gerontology)
International Journal of Molecular Medicine
October 15, 2012
Cited by 11


Related Papers